Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 647

1.

Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.

Kato F, Nio Y, Yagasaki K, Suzuki R, Hijikata M, Miura T, Miyazaki I, Tajima S, Lim CK, Saijo M, Takasaki T, Hishiki T.

Antiviral Res. 2019 Oct 31;172:104643. doi: 10.1016/j.antiviral.2019.104643. [Epub ahead of print]

PMID:
31678478
2.

Attenuation of Macrophage Migration Inhibitory Factor-Stimulated Signaling via S-Nitrosylation.

Nakahara K, Fujikawa K, Hiraoka H, Miyazaki I, Asanuma M, Ito A, Takasugi N, Uehara T.

Biol Pharm Bull. 2019;42(6):1044-1047. doi: 10.1248/bpb.b19-00025.

3.

Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice.

Miyazaki I, Isooka N, Wada K, Kikuoka R, Kitamura Y, Asanuma M.

Cells. 2019 Mar 7;8(3). pii: E221. doi: 10.3390/cells8030221.

4.

Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine.

Asanuma M, Okumura-Torigoe N, Miyazaki I, Murakami S, Kitamura Y, Sendo T.

Int J Mol Sci. 2019 Jan 30;20(3). pii: E598. doi: 10.3390/ijms20030598.

5.

Involvement of phytohormones in root elongation activity of isoprothiolane in Arabidopsis.

Kusajima M, Nagata M, Miyashita N, Yotagakiuchi Y, Maehara K, Miyazaki I, Inoue M, Fujita M, Nakashita H.

J Pestic Sci. 2018 Aug 20;43(3):186-190. doi: 10.1584/jpestics.D18-019.

6.

Involvement of 5-HT2A receptor hyperfunction in the anxiety-like behavior induced by doxorubicin and cyclophosphamide combination treatment in rats.

Nakamura Y, Kitamura Y, Sumiyoshi Y, Naito N, Kan S, Ushio S, Miyazaki I, Asanuma M, Sendo T.

J Pharmacol Sci. 2018 Nov;138(3):192-197. doi: 10.1016/j.jphs.2018.10.001. Epub 2018 Oct 9.

7.

Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.

Higashihara E, Yamamoto K, Kaname S, Okegawa T, Tanbo M, Yamaguchi T, Shigemori K, Miyazaki I, Yokoyama K, Nutahara K.

Clin Exp Nephrol. 2019 Jan;23(1):100-111. doi: 10.1007/s10157-018-1617-8. Epub 2018 Jul 26.

8.

Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan.

Yamaguchi T, Higashihara E, Okegawa T, Miyazaki I, Nutahara K.

Clin Exp Nephrol. 2018 Oct;22(5):1213-1223. doi: 10.1007/s10157-018-1574-2. Epub 2018 May 22.

PMID:
29789986
9.

Effects of expiratory muscle training on the frail elderly's respiratory function.

Chigira Y, Miyazaki I, Izumi M, Oda T.

J Phys Ther Sci. 2018 Feb;30(2):286-288. doi: 10.1589/jpts.30.286. Epub 2018 Feb 28.

10.

Editorial: Astrocyte-Targeted Therapeutic Strategies for Neurological Disorders.

Miyazaki I.

Curr Pharm Des. 2017;23(33):4933-4935. doi: 10.2174/138161282333180110125544. No abstract available.

PMID:
29022514
11.

A potentially crucial role of the PKD1 C-terminal tail in renal prognosis.

Higashihara E, Horie S, Kinoshita M, Harris PC, Okegawa T, Tanbo M, Hara H, Yamaguchi T, Shigemori K, Kawano H, Miyazaki I, Kaname S, Nutahara K.

Clin Exp Nephrol. 2018 Apr;22(2):395-404. doi: 10.1007/s10157-017-1477-7. Epub 2017 Oct 5.

12.

Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease.

Yoshida H, Higashihara E, Maruyama K, Nutahara K, Nitatori T, Miyazaki I, Shiokawa Y.

Acta Neurochir (Wien). 2017 Dec;159(12):2325-2330. doi: 10.1007/s00701-017-3316-8. Epub 2017 Sep 7.

PMID:
28884237
13.

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease.

Miyazaki I, Asanuma M.

Curr Pharm Des. 2017;23(33):4936-4947. doi: 10.2174/1381612823666170710163731. Review.

PMID:
28699520
14.

Influence of nicotine on doxorubicin and cyclophosphamide combination treatment-induced spatial cognitive impairment and anxiety-like behavior in rats.

Kitamura Y, Kanemoto E, Sugimoto M, Machida A, Nakamura Y, Naito N, Kanzaki H, Miyazaki I, Asanuma M, Sendo T.

Naunyn Schmiedebergs Arch Pharmacol. 2017 Apr;390(4):369-378. doi: 10.1007/s00210-016-1338-z. Epub 2017 Jan 7.

PMID:
28064347
16.

Neuroprotective effect of fermented papaya preparation by activation of Nrf2 pathway in astrocytes.

Murakami S, Miyazaki I, Asanuma M.

Nutr Neurosci. 2018 Apr;21(3):176-184. doi: 10.1080/1028415X.2016.1253171. Epub 2016 Nov 14.

PMID:
27841081
17.

l-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes.

Takeshima M, Miyazaki I, Murakami S, Kita T, Asanuma M.

J Clin Biochem Nutr. 2016 Sep;59(2):93-99. Epub 2016 Jul 16.

18.

3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.

Asanuma M, Miyazaki I.

BMC Neurosci. 2016 Jul 25;17(1):52. doi: 10.1186/s12868-016-0289-0.

19.

In vitro quantitative determination of the concentration of the polymerization agent methyl 2-benzoylbenzoate in intravenous injection solution and the cytotoxic effects of the chemical on normal human peripheral blood mononuclear cells.

Tsuboi C, Kawasaki Y, Yoshitome K, Yagi K, Miura T, Esumi S, Miyazaki I, Asanuma M, Kitamura Y, Sendo T.

Environ Sci Pollut Res Int. 2016 May;23(10):10262-9. doi: 10.1007/s11356-016-6332-y. Epub 2016 Apr 5.

PMID:
27044286
20.
21.

Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.

Sasaki T, Liu K, Agari T, Yasuhara T, Morimoto J, Okazaki M, Takeuchi H, Toyoshima A, Sasada S, Shinko A, Kondo A, Kameda M, Miyazaki I, Asanuma M, Borlongan CV, Nishibori M, Date I.

Exp Neurol. 2016 Jan;275 Pt 1:220-31. doi: 10.1016/j.expneurol.2015.11.003. Epub 2015 Nov 10.

PMID:
26555088
22.

Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice.

Miyazaki I, Murakami S, Torigoe N, Kitamura Y, Asanuma M.

J Neurochem. 2016 Jan;136(1):194-204. doi: 10.1111/jnc.13405. Epub 2015 Nov 10.

23.

Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation.

Kitamura Y, Hattori S, Yoneda S, Watanabe S, Kanemoto E, Sugimoto M, Kawai T, Machida A, Kanzaki H, Miyazaki I, Asanuma M, Sendo T.

Behav Brain Res. 2015 Oct 1;292:184-93. doi: 10.1016/j.bbr.2015.06.007. Epub 2015 Jun 6.

PMID:
26057360
24.

Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease.

Higashihara E, Nutahara K, Okegawa T, Tanbo M, Hara H, Miyazaki I, Kobayasi K, Nitatori T.

Nephron. 2015;129(4):253-62. doi: 10.1159/000381476. Epub 2015 Apr 16.

25.

Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice.

Murakami S, Miyazaki I, Miyoshi K, Asanuma M.

Neurochem Res. 2015 Jun;40(6):1165-78. doi: 10.1007/s11064-015-1577-2. Epub 2015 Apr 18.

PMID:
25894684
26.

Visualization of astrocytic primary cilia in the mouse brain by immunofluorescent analysis using the cilia marker Arl13b.

Kasahara K, Miyoshi K, Murakami S, Miyazaki I, Asanuma M.

Acta Med Okayama. 2014 Dec;68(6):317-22.

27.

Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan.

Higashihara E, Nutahara K, Okegawa T, Tanbo M, Mori H, Miyazaki I, Nitatori T, Kobayashi K.

Clin Exp Nephrol. 2015 Aug;19(4):746-52. doi: 10.1007/s10157-014-1047-1. Epub 2014 Oct 29.

PMID:
25351823
28.

Striatal astrocytes act as a reservoir for L-DOPA.

Asanuma M, Miyazaki I, Murakami S, Diaz-Corrales FJ, Ogawa N.

PLoS One. 2014 Sep 4;9(9):e106362. doi: 10.1371/journal.pone.0106362. eCollection 2014.

29.

Methylphenidate improves learning impairments and hyperthermia-induced seizures caused by an Scn1a mutation.

Ohmori I, Kawakami N, Liu S, Wang H, Miyazaki I, Asanuma M, Michiue H, Matsui H, Mashimo T, Ouchida M.

Epilepsia. 2014 Oct;55(10):1558-67. doi: 10.1111/epi.12750. Epub 2014 Aug 25.

30.

Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in parkinsonian mice.

Murakami S, Miyazaki I, Sogawa N, Miyoshi K, Asanuma M.

Neurotox Res. 2014 Oct;26(3):285-98. doi: 10.1007/s12640-014-9480-1. Epub 2014 Jun 13.

31.

Effect of X-ray exposure on the pharmaceutical quality of drug tablets using X-ray inspection equipment.

Uehara K, Tagami T, Miyazaki I, Murata N, Takahashi Y, Ohkubo H, Ozeki T.

Drug Dev Ind Pharm. 2015 Jun;41(6):953-8. doi: 10.3109/03639045.2014.917093. Epub 2014 May 19.

PMID:
24842380
32.

Lack of dopaminergic inputs elongates the primary cilia of striatal neurons.

Miyoshi K, Kasahara K, Murakami S, Takeshima M, Kumamoto N, Sato A, Miyazaki I, Matsuzaki S, Sasaoka T, Katayama T, Asanuma M.

PLoS One. 2014 May 15;9(5):e97918. doi: 10.1371/journal.pone.0097918. eCollection 2014.

33.

Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?

Higashihara E, Nutahara K, Tanbo M, Hara H, Miyazaki I, Kobayashi K, Nitatori T.

Nephrol Dial Transplant. 2014 Sep;29(9):1710-9. doi: 10.1093/ndt/gfu093. Epub 2014 Apr 15.

34.

Effects of (+)-8-OH-DPAT on the duration of immobility during the forced swim test and hippocampal cell proliferation in ACTH-treated rats.

Miyake A, Kitamura Y, Miyazaki I, Asanuma M, Sendo T.

Pharmacol Biochem Behav. 2014 Jul;122:240-5. doi: 10.1016/j.pbb.2014.04.003. Epub 2014 Apr 13.

PMID:
24732636
35.

Protective effects of phytochemical antioxidants against neurotoxin-induced degeneration of dopaminergic neurons.

Kita T, Asanuma M, Miyazaki I, Takeshima M.

J Pharmacol Sci. 2014;124(3):313-9. Epub 2014 Mar 4. Review.

36.

Effects of bupropion and pramipexole on cell proliferation in the hippocampus of adrenocorticotropic hormone-treated rats.

Onoue Y, Kuwatsuka K, Miyazaki I, Asanuma M, Kitamura Y, Sendo T.

Biol Pharm Bull. 2014;37(2):327-30.

37.

Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice.

Tachibana H, Ogawa D, Sogawa N, Asanuma M, Miyazaki I, Terami N, Hatanaka T, Horiguchi CS, Nakatsuka A, Eguchi J, Wada J, Yamada H, Takei K, Makino H.

Am J Physiol Renal Physiol. 2014 Jan 1;306(1):F105-15. doi: 10.1152/ajprenal.00034.2013. Epub 2013 Oct 23.

38.

Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in Parkinsonian models.

Miyazaki I, Asanuma M, Murakami S, Takeshima M, Torigoe N, Kitamura Y, Miyoshi K.

Neurobiol Dis. 2013 Nov;59:244-56. doi: 10.1016/j.nbd.2013.08.003. Epub 2013 Aug 17.

PMID:
23959140
39.

Transplantation of melanocytes obtained from the skin ameliorates apomorphine-induced abnormal behavior in rodent hemi-parkinsonian models.

Asanuma M, Miyazaki I, Diaz-Corrales FJ, Higashi Y, Namba M, Ogawa N.

PLoS One. 2013 Jun 12;8(6):e65983. doi: 10.1371/journal.pone.0065983. Print 2013.

40.

The mechanisms of electroconvulsive stimuli in BrdU-positive cells of the dentate gyrus in ACTH-treated rats.

Kuwatsuka K, Hayashi H, Onoue Y, Miyazaki I, Koyama T, Asanuma M, Kitamura Y, Sendo T.

J Pharmacol Sci. 2013;122(1):34-41. Epub 2013 Apr 25.

41.

[A small-molecule inhibitor of Pirin; TPh A].

Miyazaki I.

Nihon Rinsho. 2012 Nov;70 Suppl 8:703-8. Japanese. No abstract available.

PMID:
23513924
42.

Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression.

Sogawa N, Hirai K, Sogawa C, Ohyama K, Miyazaki I, Tsukamoto G, Asanuma M, Sasaki A, Kitayama S.

Life Sci. 2013 Apr 9;92(12):727-32. doi: 10.1016/j.lfs.2013.01.031. Epub 2013 Feb 9.

PMID:
23399700
43.

Relative intensities of prompt γ-rays from the 35Cl(n,γ)36Cl reaction with thermal neutrons as secondary γ-ray intensity standards.

Shibata M, Tojo A, Miyazaki I, Furuta M, Hayashi H, Kojima Y, Shima Y, Taniguchi A.

Appl Radiat Isot. 2013 Mar;73:60-7. doi: 10.1016/j.apradiso.2012.11.008. Epub 2012 Nov 19.

PMID:
23287705
44.

Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity.

Asanuma M, Miyazaki I, Kikkawa Y, Kimoto N, Takeshima M, Murakami S, Miyoshi K.

Neurochem Res. 2012 Sep;37(9):1944-51. doi: 10.1007/s11064-012-0813-2. Epub 2012 Jun 7.

PMID:
22674083
45.

[Investigation on the mechanisms for the suppression of cell proliferation in the dentate gyrus of the hippocampus in ACTH treated rats].

Hayashi H, Doi M, Onoue Y, Kuwatsuka K, Miyake A, Koyama T, Shinomiya K, Miyazaki I, Aasanuma M, Kitamura Y.

Yakugaku Zasshi. 2012;132(2):173-8. Review. Japanese.

46.

Effluent free radicals are associated with residual renal function and predict technique failure in peritoneal dialysis patients.

Morinaga H, Sugiyama H, Inoue T, Takiue K, Kikumoto Y, Kitagawa M, Akagi S, Nakao K, Maeshima Y, Miyazaki I, Asanuma M, Hiramatsu M, Makino H.

Perit Dial Int. 2012 Jul-Aug;32(4):453-61. doi: 10.3747/pdi.2011.00032. Epub 2012 Jan 3.

47.

Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity.

Takeshima M, Murata M, Urasoe N, Murakami S, Miyazaki I, Asanuma M, Kita T.

Neurol Res. 2011 Dec;33(10):1050-6. doi: 10.1179/1743132811Y.0000000032.

PMID:
22196758
48.

Centrosomal aggregates and Golgi fragmentation disrupt vesicular trafficking of DAT.

Diaz-Corrales FJ, Miyazaki I, Asanuma M, Ruano D, Rios RM.

Neurobiol Aging. 2012 Oct;33(10):2462-77. doi: 10.1016/j.neurobiolaging.2011.11.014. Epub 2011 Dec 16.

PMID:
22177721
49.

Factors that influence primary cilium length.

Miyoshi K, Kasahara K, Miyazaki I, Asanuma M.

Acta Med Okayama. 2011 Oct;65(5):279-85. Review.

50.

High glucose increases metallothionein expression in renal proximal tubular epithelial cells.

Ogawa D, Asanuma M, Miyazaki I, Tachibana H, Wada J, Sogawa N, Sugaya T, Kitamura S, Maeshima Y, Shikata K, Makino H.

Exp Diabetes Res. 2011;2011:534872. doi: 10.1155/2011/534872. Epub 2011 Sep 22.

Supplemental Content

Loading ...
Support Center